114 related articles for article (PubMed ID: 33979960)
1. [Expression of tuftelin protein and its clinical value in HBV-related liver cancer tissues].
Wu MN; Yang JL; Shen SJ; Wang L; Zheng WJ; Wu W; Yao M; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2021 Apr; 29(4):338-343. PubMed ID: 33979960
[No Abstract] [Full Text] [Related]
2. [Overexpression of tuftelin and KLF-5 and its clinicopathological features in hepatitis B virus-related hepatocellular carcinoma].
Yang JL; Fang RF; Xie Q; Tai BJ; Yao DF; Yao M
Zhonghua Gan Zang Bing Za Zhi; 2024 Feb; 32(2):148-154. PubMed ID: 38514264
[No Abstract] [Full Text] [Related]
3. Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth.
Wu MN; Zheng WJ; Ye WX; Wang L; Chen Y; Yang J; Yao DF; Yao M
World J Gastroenterol; 2021 Jun; 27(23):3327-3341. PubMed ID: 34163115
[TBL] [Abstract][Full Text] [Related]
4. [Effect of TUTF1 expression on the proliferation, apoptosis and prognosis of hepatocellular carcinoma cells].
Li ZJ; Li JS; Li DY; Pu T
Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):879-884. PubMed ID: 31941243
[No Abstract] [Full Text] [Related]
5. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma
Lin H; Zeng W; Lei Y; Chen D; Nie Z
Pathol Oncol Res; 2021; 27():640936. PubMed ID: 34257606
[TBL] [Abstract][Full Text] [Related]
6. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
7. Tuftelin 1 Facilitates Hepatocellular Carcinoma Progression through Regulation of Lipogenesis and Focal Adhesion Maturation.
Zhu L; Zhou KX; Ma MZ; Yao LL; Zhang YL; Li H; Du C; Yang XM
J Immunol Res; 2022; 2022():1590717. PubMed ID: 35769513
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA LINC01123 promotes the proliferation and invasion of hepatocellular carcinoma cells by modulating the miR-34a-5p/TUFT1 axis.
Xiao Z; Liu Y; Zhao J; Li L; Hu L; Lu Q; Zeng Z; Liu X; Huang D; Yang W; Xu Q
Int J Biol Sci; 2020; 16(13):2296-2305. PubMed ID: 32760198
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of PUMA expression in patients with HBV-related hepatocellular carcinoma.
Peng SL; Yao DB; Zhao Y; Xu F; Jia CJ; Xu YQ; Dai CL
Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):38-44. PubMed ID: 25635973
[TBL] [Abstract][Full Text] [Related]
10. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.
Zhang HJ; Yao DF; Yao M; Huang H; Wu W; Yan MJ; Yan XD; Chen J
World J Gastroenterol; 2012 Nov; 18(41):5897-904. PubMed ID: 23139605
[TBL] [Abstract][Full Text] [Related]
11. Evolutionary Analysis of the Mammalian Tuftelin Sequence Reveals Features of Functional Importance.
Delgado S; Deutsch D; Sire JY
J Mol Evol; 2017 Apr; 84(4):214-224. PubMed ID: 28409196
[TBL] [Abstract][Full Text] [Related]
12. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.
Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L
World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581
[TBL] [Abstract][Full Text] [Related]
13. [Expression of ZNF207 in hepatocellular carcinoma and its significance].
Zhou C; Li N
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 44(4):406-412. PubMed ID: 31113916
[TBL] [Abstract][Full Text] [Related]
14. [Value of abnormal expression of Krüppel-like zinc-finger protein transcription factor 5 in the diagnosis and prognosis of liver cancer].
Sai WL; Wang L; Sun JY; Yang JL; Yao M; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2021 Aug; 29(8):781-787. PubMed ID: 34517461
[No Abstract] [Full Text] [Related]
15. Bromodomain-containing protein 9 promotes the growth and metastasis of human hepatocellular carcinoma by activating the TUFT1/AKT pathway.
Dou C; Sun L; Wang L; Cheng J; Wu W; Zhang C; Xu Q; Tu K; Liu J
Cell Death Dis; 2020 Sep; 11(9):730. PubMed ID: 32908135
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of risk factors of tumor recurrence after liver transplantation for HBV-related hepatocellular carcinoma patients].
Li Z; Mao YG; Yu C; Gao J; Zhu JY
Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):98-101. PubMed ID: 29804374
[No Abstract] [Full Text] [Related]
17. MiR-671-5p plays a promising role in restraining osteosarcoma cell characteristics through targeting TUFT1.
Ma C; Nie ZK; Guo HM; Kong Y
J Biochem Mol Toxicol; 2020 Jul; 34(7):e22490. PubMed ID: 32115852
[TBL] [Abstract][Full Text] [Related]
18. [CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis].
Li Y; Wu D; Wei C; Yang X; Zhou S
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1509-1518. PubMed ID: 34755666
[TBL] [Abstract][Full Text] [Related]
19. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
[TBL] [Abstract][Full Text] [Related]
20. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
